BERKELEY HEIGHTS, N.J., Aug. 9, 2011 (GLOBE NEWSWIRE) -- Cyclacel Pharmaceuticals, Inc. (Nasdaq:CYCC) (Nasdaq:CYCCP) (Cyclacel or the Company), a biopharmaceutical company developing oral therapies that target the various phases of cell cycle control for the treatment of cancer and other serious disorders, will announce second quarter 2011 financial results on Thursday August 11, 2011. The Company will host a conference call and live webcast at 4:30 pm Eastern time on the same day.
